Range Biotechnologies
6 known investors
Range Bio develops next-generation diagnostic tools using translational proteomics for clinical and research applications in human health. The company serves healthcare organizations and researchers seeking advanced diagnostic capabilities.
Founders & leadership
BW
Brandon Wilson, Ph.D.Co-founder & CEO
Investors · 6
In the news
- Range Biotechnologies: Proteomics-Focused Biotech Company Completes $5.2 Million Seed Funding Roundpulse2.com · 2023
- Range Bio lands $5.2m to improve personalized health with proteomics techlongevity.technology · 2023
- Range Biotechnologies Raises $5.2M to Advance Proteomics for Precision Healthhitconsultant.net · 2023
- With the Potential to Revolutionize Personalized Health, Range Biotechnologies Receives $5.2 Million in Seed Funding Led by TechBio-Focused ARTIS Venturesglobenewswire.com · 2023
- Range Biotechnologies Raises $5.2M in Seed Fundingfinsmes.com · 2023